ASN recently established a Loan Mitigation Pilot Program to decrease the loan burden of those entering the field of nephrology and bolster interest in the specialty. The society has committed $2,700,000 to reaching those who are considering nephrology as a career. The 5-year program will provide financial support for trainees, focusing on individuals historically underrepresented in medicine.
Congratulations to the recipients of the 2021 American Society of Nephrology Lifetime and Mid-Career Awards. They have helped to improve the lives of patients with kidney diseases; advanced research, treatments, and patient care; and mentored trainees and junior faculty.
In the podcast, Bignall discusses the importance of a systems-based approach in addressing racial injustices that impact patient care, and how this approach is essential in addressing broader injustices, such as poverty, income inequality, and environmental conditions.
The American Society of Nephrology (ASN) seeks nominations for the annual election of the ASN Council, the society's governing board. Qualified candidates should have the vision, experience, and expertise to guide the society in leading the fight against kidney diseases.
Nephrology, more than any other specialty in medicine, was built on innovation. The artificial kidney-imagined, invented, and implemented by pioneers in our field-is nothing short of miraculous. In 1972, the US Congress changed federal policy to guarantee renal replacement therapy to anyone with kidney failure. With this change, dialysis "death panels" were disbanded.
Almost 50 years after the dialysis law was enacted, nephrology has taken the lead once again.
ASN continues to move forward on its commitment to dismantle systemic racism in nephrology. These are complex issues that can limit the ability of nephrologists and kidney health professionals to provide optimal care to patients or to reach their full career potential.
Taking part in the 9th Annual Kidney Health Advocacy Day, advocates from the American Association of Kidney Patients (AAKP) and ASN are urging their congressional delegations to increase funding for kidney research at the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to drive new breakthroughs for kidney patients and study the impact of COVID-19 on kidney health and people with kidney diseases.
Advocates from the American Association of Kidney Patients (AAKP) and ASN are calling on Congress to include funding for KidneyX in its annual government funding legislation and advance innovative technologies for kidney patients, such as a wearable or implantable artificial kidney.